Obesity In Indians
-
{
- All
- News
- Videos
- Web Stories
-
Health Risks Are Emerging Earlier But Staying Hidden Longer, Warns New Apollo Report
A new report published by Apollo highlights that young Indians are being exposed to health risks that are leading to chronic diseases. But the main problem is that the symptoms are being hidden for longer, leading to underdiagnosis.
-
56% Of People Consume Ultra-Processed Foods: How Your 'Quick Commerce' Diet Is Driving India's Disease Burden
India's disease burden is reaching uncontrollable levels and leading to chronic diseases. Here is what you need to know about your consumption habits of ultra-processed foods and why your quick commerce diet may be behind your long-term health declin
-
Abdominal Fat Poses Greater Health Risk Than Overall Obesity, Warns Dr Jitendra Singh
New Delhi, March 29 (IANS) Abdominal or central obesity poses a greater health risk than overall obesity, especially in the Indian context where even lean-looking individuals may carry harmful visceral fat, Minister of State Dr. Jitendra Singh said o
-
Affordable Weight Loss Drugs In India: How Cheap GLP-1s Will Affect Obesity Treatment
Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to approach this transition with caution.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
No Smoking, No Alcohol, No Obesity: Doctor Explains Heart Disease Causes In Healthy Individuals
When patients present with heart disease despite a seemingly healthy lifestyle, it necessitates a deeper, personalised investigation.
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
Cheap Generic Ozempic To Hit India: Patent Exit Sparks Weight-Loss Drug Boom
Swati Pradhan sees about 12 obesity patients a day at her clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent versions of Novo Nordisk A/S's blockbuster weight.
-
Kidney Health After 30: Why Indians Need Earlier Screening Than Ever Before
India is witnessing a worrying rise in chronic kidney disease cases, especially in young people.
-
Health Risks Are Emerging Earlier But Staying Hidden Longer, Warns New Apollo Report
A new report published by Apollo highlights that young Indians are being exposed to health risks that are leading to chronic diseases. But the main problem is that the symptoms are being hidden for longer, leading to underdiagnosis.
-
56% Of People Consume Ultra-Processed Foods: How Your 'Quick Commerce' Diet Is Driving India's Disease Burden
India's disease burden is reaching uncontrollable levels and leading to chronic diseases. Here is what you need to know about your consumption habits of ultra-processed foods and why your quick commerce diet may be behind your long-term health declin
-
Abdominal Fat Poses Greater Health Risk Than Overall Obesity, Warns Dr Jitendra Singh
New Delhi, March 29 (IANS) Abdominal or central obesity poses a greater health risk than overall obesity, especially in the Indian context where even lean-looking individuals may carry harmful visceral fat, Minister of State Dr. Jitendra Singh said o
-
Affordable Weight Loss Drugs In India: How Cheap GLP-1s Will Affect Obesity Treatment
Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to approach this transition with caution.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
No Smoking, No Alcohol, No Obesity: Doctor Explains Heart Disease Causes In Healthy Individuals
When patients present with heart disease despite a seemingly healthy lifestyle, it necessitates a deeper, personalised investigation.
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
Cheap Generic Ozempic To Hit India: Patent Exit Sparks Weight-Loss Drug Boom
Swati Pradhan sees about 12 obesity patients a day at her clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent versions of Novo Nordisk A/S's blockbuster weight.
-
Kidney Health After 30: Why Indians Need Earlier Screening Than Ever Before
India is witnessing a worrying rise in chronic kidney disease cases, especially in young people.
